Xunce (HKEX: 03317) shares surged more than 11% in early trading. As of writing, the stock is up 11.05%, trading at HK$105 with a turnover of HK$170 million.

The company recently announced a HK$2.35 billion financing round. This fundraising effort, supported by several top-tier international investment banks including Morgan Stanley and Goldman Sachs, is viewed as an "accelerator" for the company during a critical phase of AI implementation and validation. It is expected to provide substantial financial impetus to expedite AI deployment, verification, and industry expansion.

An analysis from Huatai Securities noted that Xunce is a domestic leader in scenario-based tokens, analogous to Palantir. Leveraging the high technological and client barriers established in the asset management sector, the company is actively pursuing replication and deployment across various industries. Concurrently, the TokenOS platform facilitates a business model upgrade to token-based billing, driving revenue growth.

The outlook is positive for the company to sustain high-performance growth by capitalizing on its robust real-time data technology, the benefits of cross-industry expansion, and the token-based billing model. This strategy is anticipated to unlock the company's medium to long-term growth and valuation potential.